Clinical Trials Browser

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Encephalitis, Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Autoimmune Diseases of the Nervous System, Vasculitis, Central Nervous System, Lupus Vasculitis, Central Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT04155424 2024-09-25

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Phase 2/3 Terminated

5 enrolled 15 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

NCT05491525 2024-07-03

KANGUROO

Phase 2/3 Recruiting

85 enrolled

Meningocele, Meningomyelocele, Myelitis, Transverse, Spinal Cord Injuries, Spinal Dysraphism

NCT06055998 2023-09-28

Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

Unknown

50 enrolled

Myelitis, Transverse

NCT03942952 2023-09-05

SONICS

Completed

49 enrolled

Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myelitis, Transverse, Neuromyelitis Optica, Multiple Sclerosis, Relapsing-Remitting

NCT03887273 2023-08-21

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Phase 1/2 Unknown

9 enrolled

Myelitis, Transverse

NCT05630313 2023-06-13

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Unknown

100 enrolled

Encephalomyelitis, Acute Disseminated, Myelitis, Transverse, Guillain-Barre Syndrome

NCT02003144 2022-08-23

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

Phase 3 Completed

119 enrolled 17 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

NCT02144935 2022-08-23

TMCAPTURE

Completed

106 enrolled

Myelitis, Transverse, Paraplegia

NCT05249595 2022-02-21

Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance

Phase NA Unknown

25 enrolled

Myelitis, Transverse

NCT03336762 2021-01-11

ISCoPE-TM

Completed

1 enrolled

Myelitis, Transverse

NCT00304291 2020-12-28

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

Phase 4 Completed

5 enrolled

Myelitis, Transverse, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS

NCT02591901 2020-03-18

PReSuTINeB

Phase 2 Completed

48 enrolled

Genitourinary

Urinary Bladder, Neurogenic, Multiple Sclerosis, Myelitis, Transverse, Spinal Cord Injuries, Urinary Tract Infections

NCT01892345 2019-06-26

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Phase 3 Terminated

143 enrolled 18 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

NCT02276963 2019-06-06

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Phase 1 Completed

6 enrolled 9 charts

Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis

NCT02341950 2019-02-22

Clinical Trial of a Serious Game for Individuals With SCI/D

Phase NA Completed

184 enrolled

Cone-Rod Dystrophies, Behavior, Myelitis, Transverse, Spinal Cord Diseases, Spinal Cord Injuries, Spinal Neoplasms, Spinal Stenosis, Syringomyelia, Spinal Dysraphism, Postpoliomyelitis Syndrome

NCT03138421 2019-01-25

Central Pain Study for ABX-1431

Phase 1 Completed

9 enrolled

Multiple Sclerosis, Myelitis, Transverse, Neuromyelitis Optica

NCT00179478 2017-09-06

CHAMPIONS10

Phase 4 Completed

155 enrolled 10 charts

Cerebellar Diseases, Multiple Sclerosis, Myelitis, Transverse, Optic Neuritis

NCT02398994 2016-07-20

STRIVE

Phase 3 Terminated

2 enrolled

Myelitis, Transverse, Neuromyelitis Optica

NCT00501748 2011-09-27

Safety and Tolerability of Rituximab in Neuromyelitis Optica

Phase 1 Completed

20 enrolled

Myelitis, Transverse, Neuromyelitis Optica

NCT00004645 2005-06-24

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Phase 3 Unknown

22 enrolled

Mental Disorders, Diffuse Cerebral Sclerosis of Schilder, Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myelitis, Transverse, Neurologic Manifestations, Neuromyelitis Optica, Rare Diseases

Clinical Trials

TIMELY-PLEX

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Biobank For MS And Other Demyelinating Diseases

SAA

A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

KANGUROO

Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

SONICS

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

TMCAPTURE

Ultrasound Imaging Based Sensing of Human Ankle Motion Intent and Control Strategies for Ankle Assistance

ISCoPE-TM

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

PReSuTINeB

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Clinical Trial of a Serious Game for Individuals With SCI/D

Central Pain Study for ABX-1431

CHAMPIONS10

STRIVE

Safety and Tolerability of Rituximab in Neuromyelitis Optica

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone